Hydantoin derivative

摘要

The present invention provides compounds represented by formula (1) below and pharmacologically acceptable salts thereof:;
wherein R1, R2, R3, and R4 are as defined in the claims.

主权项

1. A compound or pharmacologically acceptable salt or a hydrate or a solvate thereof, wherein the compound is 1-(3,5-dimethyl-4-(2-((4-oxo-2-(4-(trifluoromethoxy)phenyl)-1,3,8-triazaspiro[4.5]deca-1-en-8-yl)sulfonyl)ethyl)phenyl)-5,5-dimethylimidazolidine-2,4-dione.